accountWHITEHOUSE STATION, NJ (TheStreet) --U.S. regulators on Friday approved a new hepatitis C drug from Merck(MRK). More from Adam Feuerstein Biotech Stock Mailbag: CelsionRadient Pharma Defaults on Loan Market Activity Vertex Pharmaceuticals| VRTX Merck &...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Merck Hep C Drug Approved
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account